Anthrax toxin receptor 1/tumor endothelium marker 8 mediates cell spreading by coupling extracellular ligands to the actin cytoskeleton - PubMed (original) (raw)

. 2006 Aug 11;281(32):23227-36.

doi: 10.1074/jbc.M603676200. Epub 2006 Jun 8.

Affiliations

• PMID: 16762926
• DOI: 10.1074/jbc.M603676200

Free article

Anthrax toxin receptor 1/tumor endothelium marker 8 mediates cell spreading by coupling extracellular ligands to the actin cytoskeleton

Erica Werner et al. J Biol Chem. 2006.

Free article

Abstract

Tumor endothelial marker 8 (TEM8) is induced in tumor-associated vasculature and acts as a receptor for Protective Antigen (PA), the cell-binding component of the anthrax toxin determinant for toxin entrance into cells. However, the normal function for TEM8 remains unknown. We show that TEM8 functions as an adhesion molecule mediating cell spreading on immobilized PA and collagen I. The mechanism for TEM8 interaction with collagen I was cell type-specific, because binding to collagen I was abrogated by beta1 integrin function blocking antibody in HEK293 cells, but not in primary synovial rabbit fibroblasts. Binding to PA remained unaffected by the addition of beta1 integrin function blocking antibody. Whereas the extracellular and transmembrane domains of TEM8 were sufficient to provide cell attachment, the intracellular domain was critical for spreading. Fusion of the cytosolic domain of TEM8 to the IL-2 receptor, conferred cell-spreading capability on IL-2 receptor antibody substrates. The cytoplasmic domain mediated linkage with the actin cytoskeleton as it co-precipitated actin and determined partitioning of TEM8 to the actin-containing detergent insoluble cellular fraction. TEM8 anchorage to actin was relevant as spreading was inhibited by the cytoskeleton-disrupting drug cytochalasin D, but persisted in the presence of the microtubule-depolymerizing drug nocodazole, and in cells lacking intermediate filaments. Thus, our results indicate that TEM8 is a new adhesion molecule linking collagen I or PA to the actin cytoskeleton.

PubMed Disclaimer

Similar articles

• Selection of anthrax toxin protective antigen variants that discriminate between the cellular receptors TEM8 and CMG2 and achieve targeting of tumor cells.
  Chen KH, Liu S, Bankston LA, Liddington RC, Leppla SH. Chen KH, et al. J Biol Chem. 2007 Mar 30;282(13):9834-9845. doi: 10.1074/jbc.M611142200. Epub 2007 Jan 24. J Biol Chem. 2007. PMID: 17251181 Free PMC article.
• The structure of tumor endothelial marker 8 (TEM8) extracellular domain and implications for its receptor function for recognizing anthrax toxin.
  Fu S, Tong X, Cai C, Zhao Y, Wu Y, Li Y, Xu J, Zhang XC, Xu L, Chen W, Rao Z. Fu S, et al. PLoS One. 2010 Jun 18;5(6):e11203. doi: 10.1371/journal.pone.0011203. PLoS One. 2010. PMID: 20585457 Free PMC article.
• Interactions between anthrax toxin receptors and protective antigen.
  Scobie HM, Young JA. Scobie HM, et al. Curr Opin Microbiol. 2005 Feb;8(1):106-12. doi: 10.1016/j.mib.2004.12.005. Curr Opin Microbiol. 2005. PMID: 15694864 Review.
• Seneca Valley Virus Exploits TEM8, a Collagen Receptor Implicated in Tumor Growth.
  Evans DJ, Wasinger AM, Brey RN, Dunleavey JM, St Croix B, Bann JG. Evans DJ, et al. Front Oncol. 2018 Nov 6;8:506. doi: 10.3389/fonc.2018.00506. eCollection 2018. Front Oncol. 2018. PMID: 30460197 Free PMC article. Review.

Cited by

• The cell surface structure of tumor endothelial marker 8 (TEM8) is regulated by the actin cytoskeleton.
  Yang MY, Chaudhary A, Seaman S, Dunty J, Stevens J, Elzarrad MK, Frankel AE, St Croix B. Yang MY, et al. Biochim Biophys Acta. 2011 Jan;1813(1):39-49. doi: 10.1016/j.bbamcr.2010.11.013. Epub 2010 Dec 1. Biochim Biophys Acta. 2011. PMID: 21129411 Free PMC article.
• Receptors of anthrax toxin and cell entry.
  van der Goot G, Young JA. van der Goot G, et al. Mol Aspects Med. 2009 Dec;30(6):406-12. doi: 10.1016/j.mam.2009.08.007. Epub 2009 Sep 2. Mol Aspects Med. 2009. PMID: 19732789 Free PMC article. Review.
• Evolving role of seneca valley virus and its biomarker TEM8/ANTXR1 in cancer therapeutics.
  Corbett V, Hallenbeck P, Rychahou P, Chauhan A. Corbett V, et al. Front Mol Biosci. 2022 Aug 26;9:930207. doi: 10.3389/fmolb.2022.930207. eCollection 2022. Front Mol Biosci. 2022. PMID: 36090051 Free PMC article. Review.
• Overexpression of TEM8 promotes ovarian cancer progression via Rac1/Cdc42/JNK and MEK/ERK/STAT3 signaling pathways.
  Wang CX, Xiong HF, Wang S, Wang J, Nie X, Guo Q, Li X, Qi Y, Liu JJ, Lin B. Wang CX, et al. Am J Transl Res. 2020 Jul 15;12(7):3557-3576. eCollection 2020. Am J Transl Res. 2020. PMID: 32774719 Free PMC article.
• Fell-Muir Lecture: Regulatory mechanisms of skeletal and connective tissue development and homeostasis - lessons from studies of human disorders.
  Olsen BR, Berendsen AD, Besschetnova TY, Duan X, Hu K. Olsen BR, et al. Int J Exp Pathol. 2016 Aug;97(4):296-302. doi: 10.1111/iep.12198. Epub 2016 Sep 1. Int J Exp Pathol. 2016. PMID: 27581728 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • BioCyc
  • Gene Ontology
  • GlyGen glycoinformatics resource